When we talk about Italian industry, what comes to mind first? Food products, pasta, wine and olive oil, then high fashion, luxury, design, automotive and manufacturing. These are forms of excellence recognized all over the world, symbols of our know-how. But what about the pharmaceutical sector? How many people know that Italy is also a European powerhouse in this crucial field? It is fair to admit that this sector often remains in the background, overshadowed by the visibility of other more “glamorous” industries. And yet the results achieved by Italian pharmaceutical production are outstanding and deserve to be shared. The numbers speak for themselves and are indeed impressive. In 2024, the Italian pharmaceutical industry reached a production value of over €56 billion, with exports totaling €54 billion. These are far from marginal figures; we are talking about one of the driving sectors of the national economy. The impact on the Italian economy is remarkable. Between 2022 and 2024, the pharmaceutical sector recorded growth of 17.7%, compared with an overall GDP increase of just 1.4%, positioning itself as the country’s leading engine of economic development. And there is more: over the last five years, Italy has outperformed the European average, with export growth of 65% compared to 57% for the European Union. The share of medicinal exports within total manufacturing output has almost tripled over the past twenty years, rising from 3.5% in 2004 to 9.1% in 2024. The foreign trade surplus for medicines and vaccines stands at €21.2 billion, equal to 18% of total Italian manufacturing. Employment is also growing, bucking the trend seen in other industries: 71,000 employees in 2024, with an increase of 1.5% and a peak of 3% in the areas of research and development and production. A sector that not only generates value, but also creates highly skilled jobs. Behind these impressive figures, however, lies a far more complex reality when it comes to safety. The chemical-pharmaceutical sector is one of the most hazardous areas of Italian industry, not only because of fire risk, but also due to the potential for explosions, hazardous substance spills and the formation of explosive atmospheres. According to data from the National Fire Brigade, 16% of fatalities and injuries recorded in recent years are linked to explosive events, while the remaining 84% are caused by fires. In the pharmaceutical sector, many processes require the controlled use of hazardous substances and preparations: flammable liquids that release explosive vapors in confined spaces, combustible powders capable of triggering devastating explosions, and atmospheres with critical oxygen concentrations. The risks are numerous and interconnected. The presence of solvents, chemical reagents, pharmaceutical powders and potentially explosive atmospheres (ATEX) requires an integrated approach to safety. Fire protection alone is not enough; explosions must be prevented, spills managed, adequate ventilation ensured and ignition sources controlled. In this context, pharmaceutical production facilities demand the highest level of fire protection available, not only in terms of systems, but above all in terms of ongoing, qualified maintenance. An outdated or poorly maintained fire protection system in a pharmaceutical plant is not just a regulatory violation; it is a real threat to human life and to the continuity of production within one of Italy’s flagship industries. This is precisely where Mozzanica’s experience comes into play. Since its founding, the company has chosen to operate in this strategic field, understanding that the level of quality required calls for a partner that sees fire protection as an essential asset, not simply a cost to be contained. Serving the pharmaceutical sector means understanding its specific requirements. It is not enough to install fire extinguishers and detectors; it is necessary to design integrated systems that take into account explosive atmospheres, the substances involved and production processes. This calls for fire protection engineering at the highest level. Mozzanica’s Technical Department is able to deliver state-of-the-art solutions for the chemical-pharmaceutical sector, from the design of early detection systems to the implementation of dedicated fire suppression solutions, from the management of explosive atmospheres to integration with company safety systems. Every solution is tailored to the client’s specific needs, because every pharmaceutical facility has unique characteristics. But protection does not end with installation. In the pharmaceutical sector, where production cannot stop and where any downtime translates into significant financial losses as well as potential risks to public health, maintenance and monitoring are critical elements. Mozzanica has developed scheduled maintenance protocols that ensure systems operate at full efficiency 24 hours a day, 7 days a week, 365 days a year. Remote monitoring of fire protection systems in particular makes it possible to identify anomalies before they become emergencies, plan interventions without interrupting production and ensure continuous regulatory compliance. In a sector where every minute of downtime costs thousands of euros and where safety is non-negotiable, this capability makes all the difference. The Italian pharmaceutical industry is spread across the entire country, with major concentrations in Lombardy, Lazio and Tuscany, but with a significant presence in many other regions as well. To serve this sector effectively, technical expertise alone is not enough: the ability to respond quickly is also required, wherever and whenever support is needed. Mozzanica, also thanks to the opening of its Marche office in Porto Sant’Elpidio, has strengthened its ability to operate effectively across the entire Italian peninsula. This translates into a single, qualified point of contact for clients with facilities nationwide, covering every fire protection service, from design and maintenance to monitoring and emergency response. For a multinational pharmaceutical company with facilities in multiple Italian regions, being able to rely on a single partner that guarantees the same quality standards everywhere represents enormous value. It simplifies management, ensures a consistent approach and makes oversight and certification easier. Behind every life-saving medicine lies a complex and potentially hazardous production process. For this reason, guaranteeing the highest level of fire safety in this sector is not merely a regulatory obligation, but a responsibility towards workers, the community and that same Italian excellence we want to protect and help grow. In this commitment, the expertise, experience and widespread presence of specialized companies like Mozzanica represent a strategic asset for the entire sector.
252 Views The figures behind a giant that keeps growing
An extremely high-risk sector
Mozzanica: a strategic partner for a rapidly expanding sector
A widespread presence for outstanding service